文献速递消化道肿瘤放疗姑息放疗与转移瘤

直肠癌短程放疗的急性毒性:单中心经验

Acute Toxicity From Short-Course Radiation Therapy for Rectal Cancer: A Single-Institution Experience.
PubMed 文献 · Adv Radiat Oncol · 2026-05-07

本研究回顾性分析2016—2022年接受新辅助短程放疗(25 Gy/5次)的71例局部晚期直肠癌患者,30天内任何级别急性毒性发生率为75%,14%出现急性腰骶丛病(ALSP),均在1周内缓解,且ALSP与靶区剂量、小肠剂量、腰骶丛剂量及肌肉组成参数无关。

要点

  • 短程放疗后30天内任何级别急性毒性发生率为75%。
  • 14%患者出现急性腰骶丛病,中位出现时间为治疗开始后2.5天,均为一过性。
  • ALSP与靶区剂量、小肠剂量、腰骶丛剂量及肌肉组成参数无关。

核心结论

  • 短程放疗后四分之三患者出现急性毒性,14%发生一过性急性腰骶丛病且无远期后遗症。

研究设计与样本

  • 单中心回顾性分析2016—2022年局部晚期直肠癌接受新辅助短程放疗(25 Gy/5次)的71例患者。

主要发现

  • 30天内任何级别急性毒性发生率为75%,三分之一的首发毒性在短程放疗开始10天后出现。
  • 10例(14%)发生ALSP,中位出现于治疗开始后2.5天,1周内缓解,多数用非甾体抗炎药或对乙酰氨基酚处理,2例需额外药物。
  • ALSP与计划靶区剂量、小肠剂量、腰骶丛剂量及肌肉组成参数均无关。

临床怎么用

  • 短程放疗后应加强治疗窗以外的毒性监测,关注急性腰骶丛病的识别与对症处理。

局限性

  • 单中心回顾性设计,样本量有限,ALSP预测因素尚需未来研究明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Short-course radiation therapy (SCRT) is an important neoadjuvant treatment of locally advanced rectal cancer. Although SCRT offers logistical advantages and possibly reduced toxicity compared to long-course chemoradiation, emerging data have raised concerns about long-term outcomes and underrecognized adverse effects. This study examines acute toxicities after SCRT, including a poorly understood syndrome, acute lumbosacral plexopathy (ALSP). METHODS AND MATERIALS: Patients with locally advanced rectal cancer treated between 2016 and 2022 with neoadjuvant SCRT (25 Gy/5 fractions) were retrospectively analyzed. Acute toxicity was assessed up to 30 days after SCRT completion. ALSP was defined as pelvic or buttock pain with or without radiation down the lower extremities. Patients without reported ALSP were matched to cases based on N stage, tumor location, treatment position, and treatment modality, and the lumbosacral plexus and psoas muscles were contoured for matched patients. Dosimetric and clinicodemographic variables were compared for patients with and without toxicity using the Mann-Whitney U test and χ2 test. RESULTS: Among 71 patients identified, the median age was 56 years, and approximately half were female. The 30-day incidence of any-grade toxicity was 75%; one-third of first toxicities occurred more than 10 days after the start of SCRT. Notably, 10 (14%) patients developed ALSP, presenting at a median of 2.5 days after treatment initiation and resolving within 1 week. Most were treated with nonsteroidal anti-inflammatory drugs or acetaminophen, but 2 required additional medications. ALSP was not associated with planning target volume dose, small bowel dose, lumbosacral plexus dose, or muscle composition parameters. CONCLUSIONS: Three-quarters of patients treated with SCRT develop any acute toxicity, and ALSP was identified in 14% of patients. All cases of ALSP were transient, without late sequelae. These findings highlight the importance of toxicity surveillance beyond the treatment window. Future work should identify predictors of ALSP and potential mitigation strategies.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Neibart SS, Lee KN, Chen YH, et al. Acute Toxicity From Short-Course Radiation Therapy for Rectal Cancer: A Single-Institution Experience. Adv Radiat Oncol. 2026. PMID: 42110210. doi:10.1016/j.adro.2026.102053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。